1. Home
  2. DORM vs DNLI Comparison

DORM vs DNLI Comparison

Compare DORM & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorman Products Inc.

DORM

Dorman Products Inc.

HOLD

Current Price

$137.84

Market Cap

4.0B

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$22.99

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DORM
DNLI
Founded
1978
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
DORM
DNLI
Price
$137.84
$22.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
14
Target Price
$160.25
$34.33
AVG Volume (30 Days)
289.8K
2.0M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
8.14
N/A
EPS
1.43
N/A
Revenue
$2,130,319,000.00
N/A
Revenue This Year
$9.70
N/A
Revenue Next Year
$4.92
$408.85
P/E Ratio
$98.72
N/A
Revenue Growth
6.03
N/A
52 Week Low
$98.45
$12.58
52 Week High
$166.88
$27.30

Technical Indicators

Market Signals
Indicator
DORM
DNLI
Relative Strength Index (RSI) 56.60 45.25
Support Level $134.63 $18.27
Resistance Level $138.71 $23.27
Average True Range (ATR) 4.26 1.38
MACD -0.16 -0.55
Stochastic Oscillator 46.71 17.96

Price Performance

Historical Comparison
DORM
DNLI

About DORM Dorman Products Inc.

Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: